NEWS

Doctors head for exit at PE-backed IVF player Genea

MELBOURNE: Liverpool Partners’ IVF provider Genea has lost four of its key fertility ... read more

Mesoblast surges on FDA nod for its cell therapy

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more

TPG Capital chase $4b payday at clinical trials firm

MELBOURNE: TPG Capital is shaping up for a big start to the new ... read more

Integral Diagnostics chair pops up at Cura auction

SYDNEY: Partners Group is bringing in the big guns as the battle for ... read more